Asan Aorta and Peripheral Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorAsan Medical Center

About this trial

The purpose of this study is to evaluate the clinical results of patients who received revascularization of the aorta and peripheral artery at Asan Medical Center.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center

Aneurysm

Aortic dissection

Penetrating aortic ulcer

Disqualifiers

For prospective cohort, not agreeing to participate with written informed consent form

Trial population

Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Treatment

    Other intervention

    EVAR,TEVAR,PTA

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Rate of death from any cause

all-cause death

Time frame
10years
2

Rate of major Adverse Limb Events

above-ankle amputation of the index limb,major index-limb reintervention including new bypass,interposition graft revision,thrombectomy, or thrombolysis

Time frame
10years

Secondary outcomes

1

Rate of death from all cause including cardiovascular death

cardiovascular death,Non-cardiovascular death

Time frame
10years
2

Rate of stroke

Ischemic , hemorrhagic , mixed Stroke

Time frame
10years
3

Rate of myocardial Infarction

Spontaneous MI

Time frame
10years
4

Rate of vascular complication

Vascular complication

Time frame
10years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.